ATE423109T1 - Diaminderivat, herstellungsverfahren und antioxidations-arzneimittel - Google Patents

Diaminderivat, herstellungsverfahren und antioxidations-arzneimittel

Info

Publication number
ATE423109T1
ATE423109T1 AT04727146T AT04727146T ATE423109T1 AT E423109 T1 ATE423109 T1 AT E423109T1 AT 04727146 T AT04727146 T AT 04727146T AT 04727146 T AT04727146 T AT 04727146T AT E423109 T1 ATE423109 T1 AT E423109T1
Authority
AT
Austria
Prior art keywords
antioxidant
production method
diamine derivative
antioxidant drugs
treatment agent
Prior art date
Application number
AT04727146T
Other languages
English (en)
Inventor
Nobuhiro Umeda
Nobuo Mochiizuki
Seiichi Uchida
Seiichi Ikeyama
Original Assignee
Nippon Soda Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Soda Co filed Critical Nippon Soda Co
Application granted granted Critical
Publication of ATE423109T1 publication Critical patent/ATE423109T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Transplantation (AREA)
  • Endocrinology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
AT04727146T 2003-04-14 2004-04-13 Diaminderivat, herstellungsverfahren und antioxidations-arzneimittel ATE423109T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003109665 2003-04-14
JP2004022719 2004-01-30

Publications (1)

Publication Number Publication Date
ATE423109T1 true ATE423109T1 (de) 2009-03-15

Family

ID=33302206

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04727146T ATE423109T1 (de) 2003-04-14 2004-04-13 Diaminderivat, herstellungsverfahren und antioxidations-arzneimittel

Country Status (10)

Country Link
US (1) US7652155B2 (de)
EP (1) EP1614684B8 (de)
JP (1) JP4369924B2 (de)
AT (1) ATE423109T1 (de)
AU (1) AU2004230369B2 (de)
CA (1) CA2522051C (de)
DE (1) DE602004019508D1 (de)
DK (1) DK1614684T3 (de)
ES (1) ES2320995T3 (de)
WO (1) WO2004092153A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006309576B2 (en) * 2005-11-04 2010-04-15 Nippon Soda Co., Ltd. Ortho-substituted aniline derivative and antioxidant drug
ES2289957B1 (es) * 2007-02-07 2008-12-01 Universidad Complutense De Madrid Fuente de iluminacion con emision reducida de longitudes de onda corta para la proteccion de ojos.

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5569567A (en) 1978-11-21 1980-05-26 Eisai Co Ltd Novel imidazole compound, and antidepressant containing the same
DE3407505A1 (de) 1984-03-01 1985-09-05 A. Nattermann & Cie GmbH, 5000 Köln Neue benzothiazin-carbonsaeureamide mit antiarthritischer wirksamkeit
WO1986000887A1 (fr) 1984-08-01 1986-02-13 Takeda Chemical Industries, Ltd. Derives de quinone, leur procede de preparation et composition medicinale les contenant
JP2748415B2 (ja) 1987-07-29 1998-05-06 武田薬品工業株式会社 ヒドロキサム酸誘導体
CA1338238C (en) 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
JP2855340B2 (ja) 1988-06-10 1999-02-10 武田薬品工業株式会社 ２―置換クマラン誘導体
JPH02121975A (ja) 1988-10-28 1990-05-09 Eisai Co Ltd ２，３−ジヒドロベンゾフラン誘導体
US5093351A (en) 1989-01-05 1992-03-03 Du Pont Merck Pharmaceutical Company Substituted indole, benzofuran and benzothiophene derivatives as 5-lipoxygenase inhibitors
US5128351A (en) 1990-05-04 1992-07-07 American Cyanamid Company Bis-aryl amide and urea antagonists of platelet activating factor
TW199152B (de) * 1990-11-01 1993-02-01 Takeda Pharm Industry Co Ltd
AU670433B2 (en) 1992-04-06 1996-07-18 Merrell Dow Pharmaceuticals Inc. Novel derivatives of 2,3-dihydro-benzofuranols
JP3162175B2 (ja) * 1992-05-06 2001-04-25 エーザイ株式会社 クロマン誘導体若しくはジヒドロベンゾフラン誘導体
JP2656720B2 (ja) 1992-12-09 1997-09-24 武田薬品工業株式会社 光学活性アミノクマラン誘導体
JPH06287139A (ja) 1993-02-02 1994-10-11 Takeda Chem Ind Ltd 網膜疾患の予防および治療剤
CA2189068A1 (en) 1994-04-27 1995-11-02 Nobuo Mochizuki Imidazole derivative and process for producing the same
KR19980702883A (ko) 1995-03-10 1998-08-05 스티븐엘.네스비트 2,3-디히드로-벤조푸라놀 유도체의 신규 제조 방법
WO2000006550A1 (en) 1998-07-31 2000-02-10 Nippon Soda Co., Ltd. Phenylazole compounds, process for producing the same and drugs for hyperlipemia
IT1302125B1 (it) 1998-08-03 2000-07-31 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante ed antiproliferativacomprendente una carnitina ed un carotenoide
US7008940B1 (en) 1999-08-20 2006-03-07 Takeda Pharmaceutical Company Limited Dihydrobenzofuran derivatives, process for the preparing thereof and agents
WO2001014834A1 (de) 1999-08-23 2001-03-01 Gwt Global Weighing Technologies Gmbh Schwundmeldeanlage und verfahren zur schwundmeldung
AU2001241084A1 (en) 2000-03-13 2001-09-24 Taisho Pharmaceutical Co. Ltd. Imidazolylbenzophenone derivatives
JPWO2003022821A1 (ja) 2001-09-06 2004-12-24 大正製薬株式会社 ２０−ｈｅｔｅ産生酵素阻害作用を有するヘテロ環誘導体

Also Published As

Publication number Publication date
AU2004230369B8 (en) 2004-10-28
ES2320995T3 (es) 2009-06-01
CA2522051C (en) 2009-11-17
JP4369924B2 (ja) 2009-11-25
EP1614684A4 (de) 2007-09-05
US7652155B2 (en) 2010-01-26
DK1614684T3 (da) 2009-04-14
CA2522051A1 (en) 2004-10-28
US20060194872A1 (en) 2006-08-31
EP1614684B1 (de) 2009-02-18
JPWO2004092153A1 (ja) 2006-07-06
EP1614684B8 (de) 2009-08-05
WO2004092153A1 (ja) 2004-10-28
EP1614684A1 (de) 2006-01-11
AU2004230369B2 (en) 2008-01-10
AU2004230369A1 (en) 2004-10-28
DE602004019508D1 (de) 2009-04-02

Similar Documents

Publication Publication Date Title
MY142807A (en) Benzimidazole derivative and use thereof.
NO20071719L (no) Pyridylinhibitorer for "hedgehog"-signalisering
MXPA04009784A (es) Tiazolidin-4-carbonitrilos y analogos y su uso como inhibidores de dipeptidil-peptidas.
MY150630A (en) Amide derivative and insecticide containing the same
SE0303180D0 (sv) Novel compounds
SE0302232D0 (sv) Novel Compounds
ATE366249T1 (de) Zyklische amid-derivate
UY26872A1 (es) Derivados de la 4- fenil piridina
NO20070606L (no) Inhibitorer av IAP
EA200870321A1 (ru) Способ получения 4-оксохинолинового соединения
DK1063228T3 (da) Cycloalkenderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf
TW200510317A (en) Caspase inhibitors and uses thereof
NO20063275L (no) Anvendelse av substituerte 2-aminotetraliner for forebyggende behandling av Parkinsons sykdom
TW200505922A (en) Substituted 8-perfluoroalkyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives
EP1775289A4 (de) Neue imidazolidinderivate
ATE260898T1 (de) Substituierte vinylpyridinderivate und arzneimittel, die diese enthalten
NO20055632L (no) Aromatiske oksyfenyl- og aromatiske sulfanylfenylderivater
EA200700572A1 (ru) Соединение 2-морфолино-4-пиримидона
SG161217A1 (en) New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents
TW200626573A (en) Pyrimidone compound
DE60335404D1 (de) Verwendung von 4-aminochinolin-verbindungen zur behandlung entzündlicher erkrankungen des auges
TW200607789A (en) Diamine derivatives, process for preparation thereof, and fungicide comprising diamine derivative as an active ingredient
MY138466A (en) Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders
NO20076000L (no) Aminosyrederivater
ATE513821T1 (de) Thiadiazolin-derivate zur behandlung von krebs

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties